Trial intelligence / Profile preview

Nabilone for Spasticity and Neuropathic Pain in SCI

NCT01222468Phase 2Completed

Sponsor
University of Manitoba
Start
Jun 2012
Primary completion
Feb 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of nabilone in Spasticity, neuropathic pain, sponsored by University of Manitoba. Started Jun 2012; status: completed.

02

Drugs

nabilone
03

Conditions

Spasticityneuropathic pain

Beyond the preview

Go deeper on NCT01222468.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01222468.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call